BACKGROUND: Extracorporeal photopheresis (ECP) is considered to be a promising
immunomodulatory therapy in diseases caused by aberrant T lymphocytes. ECP has been …

Extracorporeal photopheresis (ECP) is an immunomodulation procedure that may be used
as an adjunct therapy in patients with cutaneous T cell leukemia/lymphoma, graftversus-host …

Background Extracorporeal photopheresis (ECP) is a well-established but lengthy and
burdensome cell-based therapy for various diseases such as cutaneous T-cell lymphoma …

Bei der extrakorporalen Photopherese (ECP) handelt sich um ein von der PUVA-Therapie
abgeleitetes Therapiekonzept, das Leukapherese mit der Photochemotherapie verbindet …

2. Methods Two distinct panels of experts met several times from 2010 to 2011 to address
the PBSC-related issues (components: PP, MM, CM, LS, MR, FR, PA, LP and BA) and those …

Background Extracorporeal photopheresis (ECP) is associated with few adverse effects. We
have anecdotally noted patients treated with long‐term ECP develop iron deficiency anemia …

Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …

Extracorporeal photochemotherapy (ECP) has been applied to many T-cell mediated
diseases where immunosuppressive drugs are insufficient or not tolerated. As ECP is mainly …

Background: Scleroderma is a heterogeneous group of diseases that can be localized or
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …

PBAC Submission Application Number 1420 to the Medical Services Advisory Committee For
the listing of integrated, closed-system ECP systems For the treatment of acute and chronic …